GB2053924B - Immunosuppressive 3-hemiesters of7-oxygenated cholesterol - Google Patents

Immunosuppressive 3-hemiesters of7-oxygenated cholesterol

Info

Publication number
GB2053924B
GB2053924B GB8018483A GB8018483A GB2053924B GB 2053924 B GB2053924 B GB 2053924B GB 8018483 A GB8018483 A GB 8018483A GB 8018483 A GB8018483 A GB 8018483A GB 2053924 B GB2053924 B GB 2053924B
Authority
GB
United Kingdom
Prior art keywords
hemiesters
immunosuppressive
oxygenated cholesterol
oxygenated
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8018483A
Other languages
English (en)
Other versions
GB2053924A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Publication of GB2053924A publication Critical patent/GB2053924A/en
Application granted granted Critical
Publication of GB2053924B publication Critical patent/GB2053924B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
GB8018483A 1979-06-20 1980-06-05 Immunosuppressive 3-hemiesters of7-oxygenated cholesterol Expired GB2053924B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7676779A JPS563000A (en) 1979-06-20 1979-06-20 Water-soluble cholesterol derivative

Publications (2)

Publication Number Publication Date
GB2053924A GB2053924A (en) 1981-02-11
GB2053924B true GB2053924B (en) 1983-04-27

Family

ID=13614739

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8018483A Expired GB2053924B (en) 1979-06-20 1980-06-05 Immunosuppressive 3-hemiesters of7-oxygenated cholesterol

Country Status (7)

Country Link
US (1) US4304726A (enExample)
JP (1) JPS563000A (enExample)
CA (1) CA1154755A (enExample)
DE (1) DE3022788C2 (enExample)
FR (1) FR2459248A1 (enExample)
GB (1) GB2053924B (enExample)
SE (1) SE445833B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174870D1 (en) * 1981-03-13 1986-07-31 Green Cross Corp Water-soluble cholesterol derivatives
JPS60258198A (ja) * 1984-06-04 1985-12-20 Amano Pharmaceut Co Ltd トリテルペンアルコ−ル有機酸エステル及びその製造法
DE3803757A1 (de) * 1988-02-08 1989-08-17 Boehringer Mannheim Gmbh Cholesterin-esterase-farbsubstrat
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
FI974648A7 (fi) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö
KR20020028876A (ko) 1999-04-30 2002-04-17 추후제출 스테로이드 유도체
WO2002062302A2 (en) * 2001-02-08 2002-08-15 The University Of Chicago Steroidal derivatives
CA2446314C (en) * 2001-05-03 2011-02-22 The University Of Chicago Liver x receptor agonists
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
JP4272518B2 (ja) * 2001-09-07 2009-06-03 栄次 松浦 β２−グリコプロテインＩに対するリガンド及びその用途
AU2003228485A1 (en) * 2002-04-12 2003-10-27 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US20100048912A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
AU2010210422A1 (en) * 2009-02-05 2011-08-18 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
JP2013500986A (ja) * 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓ｘ受容体アゴニスト
EP2522350B1 (de) * 2011-05-12 2013-07-31 Immunopharm AG Verwendung der Wirkstoffkombination aus einem 1-Diethylaminoethyl-3-Chinoxalin-2-on Derivat und einem Oxysterol zur Durchbrechung von Resistenzen bei der Behandlung von Krebs und zur Erhöhung der Immunleistungsfähigkeit bei Krebs, bakteriellen und viralen Erkrankungen, Autoimmunerkrankungen, erhöhter Stress- und Umweltbelastung
EP4066841A1 (en) 2013-03-14 2022-10-05 University of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) * 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
GB1553540A (en) * 1977-02-23 1979-09-26 Green Cross Corp Medicaments containing cholesterol derivatives
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
US4189400A (en) * 1977-08-17 1980-02-19 Bonderman Dean P Compound useful in cholesterol assay procedures
US4225525A (en) * 1979-02-08 1980-09-30 Hoffmann-La Roche Inc. Vitamin D3 metabolite derivatives

Also Published As

Publication number Publication date
JPS563000A (en) 1981-01-13
CA1154755A (en) 1983-10-04
SE445833B (sv) 1986-07-21
FR2459248A1 (fr) 1981-01-09
US4304726A (en) 1981-12-08
GB2053924A (en) 1981-02-11
DE3022788C2 (de) 1982-08-12
FR2459248B1 (enExample) 1983-10-28
SE8004125L (sv) 1980-12-21
DE3022788A1 (de) 1981-01-08

Similar Documents

Publication Publication Date Title
GB2059256B (en) Support
JPS5593482A (en) Hinge structure
GB2053924B (en) Immunosuppressive 3-hemiesters of7-oxygenated cholesterol
JPS56133050A (en) Separator
GB2049183B (en) Pollution-sensitive elements
GB2046994B (en) Insulatorsemiconductor structure
DE3064089D1 (en) Separator
JPS55157359A (en) Separator
JPS55152651A (en) Two stage masterrcylinder
JPS55137956A (en) Sheettshaped structure
GB2049070B (en) Bearings
GB2051918B (en) Volume-enclosing structure
JPS5642692A (en) Note
JPS5690412A (en) Magneticchead structure
JPS5628661A (en) Separator
JPS55116949A (en) Panel
JPS5611298A (en) Note
JPS5611246A (en) Resinnmetal complex
AU526324B2 (en) Buildibg structure
JPS5613161A (en) Fireeresisting panel
JPS55155153A (en) Separator
JPS566853A (en) Panel
JPS5595558A (en) Fireeproof panel
JPS5555855A (en) Fireeproofing panel
JPS5595596A (en) Squeezeeout note

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee